Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin for therapist-patient physiological synchrony in severe mental illness
MOH_2022-06-20_011856Phase 2Not yet recruiting
- Sponsor
- ד"ר חגי מעוז
- Start
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in mental disorder comparing Oxytocin with Placebo (2 arms). Primary endpoints: Physiological synchrony and Perceived therapist empathy. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
mental disorder
Beyond the preview
Go deeper on MOH_2022-06-20_011856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2022-06-20_011856.